Literature DB >> 18179902

22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome.

Shay Ben-Shachar1, Zhishuo Ou, Chad A Shaw, John W Belmont, Millan S Patel, Marybeth Hummel, Stephen Amato, Nicole Tartaglia, Jonathan Berg, V Reid Sutton, Seema R Lalani, A Craig Chinault, Sau W Cheung, James R Lupski, Ankita Patel.   

Abstract

Microdeletions within chromosome 22q11.2 cause a variable phenotype, including DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS). About 97% of patients with DGS/VCFS have either a common recurrent approximately 3 Mb deletion or a smaller, less common, approximately 1.5 Mb nested deletion. Both deletions apparently occur as a result of homologous recombination between nonallelic flanking low-copy repeat (LCR) sequences located in 22q11.2. Interestingly, although eight different LCRs are located in proximal 22q, only a few cases of atypical deletions utilizing alternative LCRs have been described. Using array-based comparative genomic hybridization (CGH) analysis, we have detected six unrelated cases of deletions that are within 22q11.2 and are located distal to the approximately 3 Mb common deletion region. Further analyses revealed that the rearrangements had clustered breakpoints and either a approximately 1.4 Mb or approximately 2.1 Mb recurrent deletion flanked proximally by LCR22-4 and distally by either LCR22-5 or LCR22-6, respectively. Parental fluorescence in situ hybridization (FISH) analyses revealed that none of the available parents (11 out of 12 were available) had the deletion, indicating de novo events. All patients presented with characteristic facial dysmorphic features. A history of prematurity, prenatal and postnatal growth delay, developmental delay, and mild skeletal abnormalities was prevalent among the patients. Two patients were found to have a cardiovascular malformation, one had truncus arteriosus, and another had a bicuspid aortic valve. A single patient had a cleft palate. We conclude that distal deletions of chromosome 22q11.2 between LCR22-4 and LCR22-6, although they share some characteristic features with DGS/VCFS, represent a novel genomic disorder distinct genomically and clinically from the well-known DGS/VCF deletion syndromes.

Entities:  

Mesh:

Year:  2008        PMID: 18179902      PMCID: PMC2253964          DOI: 10.1016/j.ajhg.2007.09.014

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  A 22q11.2 deletion that excludes UFD1L and CDC45L in a patient with conotruncal and craniofacial defects.

Authors:  S C Saitta; J M McGrath; H Mensch; T H Shaikh; E H Zackai; B S Emanuel
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  Microdeletion 22q11.2: clinical data and deletion size.

Authors:  W S Kerstjens-Frederikse; H Kurahashi; D A Driscoll; M L Budarf; B S Emanuel; B Beatty; T Scheidl; J Siegel-Bartelt; K Henderson; C Cytrynbaum; G Nie; I Teshima
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

3.  Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities.

Authors:  J B Ravnan; J H Tepperberg; P Papenhausen; A N Lamb; J Hedrick; D Eash; D H Ledbetter; C L Martin
Journal:  J Med Genet       Date:  2005-09-30       Impact factor: 6.318

Review 4.  Role of MAPKs in development and differentiation: lessons from knockout mice.

Authors:  M Aouadi; B Binetruy; L Caron; Y Le Marchand-Brustel; F Bost
Journal:  Biochimie       Date:  2006-06-27       Impact factor: 4.079

5.  Genome structural variation and sporadic disease traits.

Authors:  James R Lupski
Journal:  Nat Genet       Date:  2006-09       Impact factor: 38.330

6.  Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect.

Authors:  Jennifer A Lee; Ricardo E Madrid; Karen Sperle; Carolyn M Ritterson; Grace M Hobson; James Garbern; James R Lupski; Ken Inoue
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

7.  Annual summary of vital statistics: 2005.

Authors:  Brady E Hamilton; Arialdi M Miniño; Joyce A Martin; Kenneth D Kochanek; Donna M Strobino; Bernard Guyer
Journal:  Pediatrics       Date:  2007-02       Impact factor: 7.124

8.  Trisomy 18 in neonates: prenatal diagnosis, clinical features, therapeutic dilemmas and outcome.

Authors:  Barbara Goc; Zofia Walencka; Agata Włoch; Ewa Wojciechowska; Danuta Wiecek-Włodarska; Joanna Krzystolik-Ładzińska; Klaudiusz Bober; Janusz Swietliński
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

9.  Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2.

Authors:  A Rauch; S Zink; C Zweier; C T Thiel; A Koch; R Rauch; J Lascorz; U Hüffmeier; M Weyand; H Singer; M Hofbeck
Journal:  J Med Genet       Date:  2005-04-14       Impact factor: 6.318

10.  A common molecular basis for rearrangement disorders on chromosome 22q11.

Authors:  L Edelmann; R K Pandita; E Spiteri; B Funke; R Goldberg; N Palanisamy; R S Chaganti; E Magenis; R J Shprintzen; B E Morrow
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

View more
  68 in total

1.  Sixteen New Cases Contributing to the Characterization of Patients with Distal 22q11.2 Microduplications.

Authors:  J Wincent; D L Bruno; B W M van Bon; A Bremer; H Stewart; E M H F Bongers; C W Ockeloen; M H Willemsen; D D A Keays; G Baird; D F Newbury; T Kleefstra; C Marcelis; U Kini; Z Stark; R Savarirayan; L J Sheffield; O Zuffardi; H R Slater; B B de Vries; S J L Knight; B-M Anderlid; J Schoumans
Journal:  Mol Syndromol       Date:  2011-05-18

2.  High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasia.

Authors:  Serena Nik-Zainal; Reiner Strick; Mekayla Storer; Ni Huang; Roland Rad; Lionel Willatt; Tomas Fitzgerald; Vicki Martin; Richard Sandford; Nigel P Carter; Andreas R Janecke; Stefan P Renner; Patricia G Oppelt; Peter Oppelt; Christine Schulze; Sara Brucker; Matthew Hurles; Matthias W Beckmann; Pamela L Strissel; Charles Shaw-Smith
Journal:  J Med Genet       Date:  2011-01-28       Impact factor: 6.318

3.  Effect of copy number variants on outcomes for infants with single ventricle heart defects.

Authors:  Abigail S Carey; Li Liang; Jonathan Edwards; Tracy Brandt; Hui Mei; Andrew J Sharp; Daphne T Hsu; Jane W Newburger; Richard G Ohye; Wendy K Chung; Mark W Russell; Jill A Rosenfeld; Lisa G Shaffer; Michael K Parides; Lisa Edelmann; Bruce D Gelb
Journal:  Circ Cardiovasc Genet       Date:  2013-09-10

4.  Human gene copy number spectra analysis in congenital heart malformations.

Authors:  Aoy Tomita-Mitchell; Donna K Mahnke; Craig A Struble; Maureen E Tuffnell; Karl D Stamm; Mats Hidestrand; Susan E Harris; Mary A Goetsch; Pippa M Simpson; David P Bick; Ulrich Broeckel; Andrew N Pelech; James S Tweddell; Michael E Mitchell
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

5.  Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region.

Authors:  Justine Coppinger; Donna McDonald-McGinn; Elaine Zackai; Kate Shane; Joan F Atkin; Alexander Asamoah; Robert Leland; David D Weaver; Susan Lansky-Shafer; Karen Schmidt; Heidi Feldman; William Cohen; Judy Phalin; Berkley Powell; Blake C Ballif; Aaron Theisen; Elizabeth Geiger; Chad Haldeman-Englert; Tamim H Shaikh; Sulagna Saitta; Bassem A Bejjani; Lisa G Shaffer
Journal:  Hum Mol Genet       Date:  2009-02-03       Impact factor: 6.150

6.  Population analysis of large copy number variants and hotspots of human genetic disease.

Authors:  Andy Itsara; Gregory M Cooper; Carl Baker; Santhosh Girirajan; Jun Li; Devin Absher; Ronald M Krauss; Richard M Myers; Paul M Ridker; Daniel I Chasman; Heather Mefford; Phyllis Ying; Deborah A Nickerson; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2009-01-22       Impact factor: 11.025

Review 7.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

8.  Microdeletions and microduplications in patients with congenital heart disease and multiple congenital anomalies.

Authors:  Elizabeth Goldmuntz; Prasuna Paluru; Joseph Glessner; Hakon Hakonarson; Jaclyn A Biegel; Peter S White; Xiaowu Gai; Tamim H Shaikh
Journal:  Congenit Heart Dis       Date:  2011-10-20       Impact factor: 2.007

9.  Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development.

Authors:  Jason Newbern; Jian Zhong; Rasika S Wickramasinghe; Xiaoyan Li; Yaohong Wu; Ivy Samuels; Natalie Cherosky; J Colleen Karlo; Brianne O'Loughlin; Jamie Wikenheiser; Madhusudhana Gargesha; Yong Qiu Doughman; Jean Charron; David D Ginty; Michiko Watanabe; Sulagna C Saitta; William D Snider; Gary E Landreth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

Review 10.  MAP'ing CNS development and cognition: an ERKsome process.

Authors:  Ivy S Samuels; Sulagna C Saitta; Gary E Landreth
Journal:  Neuron       Date:  2009-01-29       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.